MONA (Morphine, Oxygen, Nitrates, Aspirin) is considered outdated for treating Acute Coronary Syndrome (ACS) because studies indicate some components, specifically morphine and oxygen, may cause harm or increase mortality rather than providing benefit. Modern, evidence-based care has shifted toward faster, more targeted therapies like percutaneous coronary intervention (PCI), rendering the old, rigid mnemonic obsolete in favor of more comprehensive protocols.
Continuing to use the outdated MONA mnemonic may negatively affect the treatment of ACS patients because other drugs that effectively reduce mortality or coronary outcomes are not contained in this mnemonic. A newly trained student or a less experienced physician may misinterpret MONA as being sufficient to treat ACS.
It stands for Morphine, Oxygen, Nitroglycerine and Aspirin. These new data probably will be the final stone on the grave of “MONA” in the management of ACS. Life support providers might think of a mnemonic like “SNAAP” standing for Statin, Nitroglycerine, Aspirin, Anticoagulation and Plavix/Prasugrel or similar.
MONA stands for “morphine, oxygen, nitroglycerin, and aspirin.” The logic behind these medications or interventions is to vasodilate the blood vessels, relieve pain, and increase perfusion to the heart muscle.
Since unstable angina is not relieved by rest, the health care provider (HCP) will prescribe MONA – morphine, oxygen, nitrogen, and aspirin. MONA is a mnemonic to remember the best treatment practice in the care of unstable angina. MONA has shown promising results in decreasing events that can lead to death.
This agent is indicated to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome (ACS)—that is, unstable angina, non-ST elevation MI (NSTEMI), or ST-elevation MI (STEMI).
You may administer 1 or 2 sprays of Nitroglycerin oral spray at the onset of chest pain. If the pain continues after 5 minutes, a third spray may be used. You must wait 5 minutes after the first 1 or 2 sprays before using a third spray.
Montelukast may cause some people to be agitated, disoriented, irritable, or display other abnormal behaviors. It may also cause some people to have suicidal thoughts and tendencies or to become more depressed.
The effect of Monas 10 mg Tablet can be observed after 1-3 hours of administration. Monas 10 mg Tablet is not a fast-acting rescue medicine for asthma attacks and needs to be taken daily to work properly.
In summary, the totality of evidence now suggests that patients with HFrEF should be treated early with a combination of the four drugs: an ARNI, beta-blocker, MRA, and SGLT2 inhibitor in order to benefit from substantial and sustained reductions of mortality, heart failure hospitalizations, and symptoms.
The "4 E's of Angina" are common triggers that increase the heart's workload, leading to chest pain, and stand for Exercise, Emotional stress, Eating a large meal, and exposure to Extreme cold weather. These factors demand more oxygen from the heart, and if blood flow is restricted, angina pain occurs; they typically affect stable angina and usually resolve with rest or medicine, notes the NHS and Cleveland Clinic.
There is a move in hospitals to restrict the use of meperidine as a result of adverse events such as neurotoxicity from the normeperidine metabolite, delirium in elderly patients, and serotonin syndrome. In addition, reports of medication errors with meperidine have prompted a review of its place in therapy.
Alawi suffers from Type 1 diabetes, a disease she was diagnosed with in 2011, the year she started her career in show business. As a result, she has to maintain a strict daily regimen of insulin self-injections and avoiding foods and drinks rich in sugar and carbohydrates.
Although montelukast is considered to be a safe drug, there are concerns regarding adverse drug reactions, including the rare occurrence of Churg-Strauss syndrome and, despite insufficient data, the possibility of neuropsychiatric events such as anxiety, depression, sleep disturbance, and suicidality.
Indeed, montelukast reduced LV mass (p < 0.05) and remote wall thickening (p < 0.05), and improved cardiac pumping function, as evidenced by increased global ejection fraction (p < 0.01), and regional contractility in infarcted (p < 0.05) and in remote non-infarcted (p < 0.05) myocardium.
Clinically apparent liver injury from montelukast is rare; but more than a dozen cases reported in the literature. In these cases, the latency to onset of injury was highly variable, ranging from a few days to several years. Patients presented with anorexia, nausea, right upper quadrant pain, dark urine, and jaundice.
In addition to representing Jakarta, Monas also represents the Indonesian people's fight for independence. Monas was founded to honor Indonesia's independence and struggle. Indonesia proclaimed its independence from Dutch colonial rule on August 17, 1945.
Do not administer to patients with a blood pressure < 110 mmHg or who are exhibiting signs of significant hypoperfusion. Use with caution in patients with hepatic or renal insufficiency. Exercise caution (and rule out right-sided involvement) in patients with documented inferior ischemia on 12-lead ECG.
Introduction: It is often believed that chest pain relieved by nitroglycerin is indicative of coronary artery disease origin. Objective: To determine if relief of chest pain with nitroglycerin can be used as a diagnostic test to help differentiate cardiac chest pain and non-cardiac chest pain.
